Chicago Equity Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Chicago Equity Partners’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$493K	Sell	7,830 -4,499	-36%	-$404K	0.05%	429
2019 Q4	$1.53M	Sell	12,329 -17,025	-58%	-$1.52M	0.09%	339
2019 Q3	$1.95M	Sell	29,354 -55	-0.2%	-$3.69K	0.09%	325
2019 Q2	$2.34M	Buy	29,409 +7,539	+34%	+$675K	0.1%	284
2019 Q1	$2.45M	Buy	21,870 +12,940	+145%	+$1.41M	0.09%	299
2018 Q4	$900K	Buy	8,930 +7,230	+425%	+$749K	0.04%	509
2018 Q3	$215K	Buy	+1,700	New	+$180K	0.01%	776

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Chicago Equity Partners's ICPT Position: Q1 2020 in Review

Chicago Equity Partners reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 36% in Q1 2020, selling an estimated $404K and leaving 7,830 shares worth $493K. The position accounts for 0.05% of the portfolio, ranked #429.

Chicago Equity Partners first reported a position in ICPT in Q3 2018 and has held it in 7 quarters since. The position peaked at $2.45M in Q1 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

Chicago Equity Partners held 7,830 shares of Intercept Pharmaceuticals, Inc. worth $493K as of Q1 2020.
Chicago Equity Partners sold 4,499 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $404K.
Intercept Pharmaceuticals, Inc. made up 0.05% of Chicago Equity Partners's portfolio in Q1 2020, its #429 holding.
Chicago Equity Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and has held it in 7 quarters since.
Chicago Equity Partners's Intercept Pharmaceuticals, Inc. position peaked at $2.45M in Q1 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.